HF2476
Over-the-counter allergy medicine sale restrictions modified.
Legislative Session 94 (2025-2026)
Related bill: SF3087
AI Generated Summary
Purpose of the Bill
The purpose of this bill is to modify the restrictions on the sale and purchase of certain over-the-counter (OTC) allergy medicines, specifically those containing methamphetamine precursor drugs like ephedrine and pseudoephedrine.
Main Provisions
Sale Restrictions: The bill places limits on the amount of methamphetamine precursor drugs that can be sold in a single OTC transaction. No more than two packages or a total weight of six grams of the precursor drugs can be sold in one sale.
Purchase Limits: Individuals cannot acquire more than seven grams of methamphetamine precursor drugs within a 30-day period through OTC sales.
Display and Sales Authorization: Methamphetamine precursor drugs must be displayed behind a checkout counter and sold only by a licensed pharmacist, pharmacy technician, or pharmacy clerk. Buyers must provide photographic identification and sign a record of the sale, which must be kept for three years.
Age Restrictions: It is prohibited to sell methamphetamine precursor drugs to individuals under 18 years old. Sellers have a defense if they reasonably relied on proof of age.
Criminal Penalties: Violators of these restrictions may face a misdemeanor charge, with potential imprisonment up to 90 days or a fine up to $1,000, or both.
Protection for Businesses: Business owners and supervisors are protected from criminal penalties if an employee violates these provisions without their knowledge, and if a training program was provided on relevant laws.
Exemptions: Certain products are exempt from these restrictions, including pediatric products for children under 12, certified methamphetamine-resistant products, gel capsule or liquid forms, and products where pseudoephedrine is less than 1% of total weight.
Record Keeping and Reporting: Employees must report suspicious transactions involving precursors, with protection from civil liability for good-faith reports.
Significant Changes to Existing Law
- Local Ordinance Preemption: This bill preempts any local ordinances regulating the sale of products containing ephedrine or pseudoephedrine, making those enacted prior to this bill void.
Relevant Terms
- Methamphetamine precursor drugs
- Ephedrine
- Pseudoephedrine
- Over-the-counter (OTC) sale
- Pharmacist
- Misdemeanor
- Pediatric products
- Drug purchase limits
- Sale restrictions
- Local ordinance preemption
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 17, 2025 | House | Action | Introduction and first reading, referred to | Health Finance and Policy |
Bill information comes from public records published by the Office of the Revisor of Statutes, the Minnesota House and the Minnesota Senate. AI summaries are written by MinneSlate and are not official. MinneSlate is independent and is not affiliated with the State of Minnesota or the Minnesota Legislature.